Shares of Dyne Therapeutics, Inc. DYN, a clinical-stage muscle disease company, tumbled 30.7% on two key announcements. The company announced that some of its senior executives have stepped down from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results